These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2418432)

  • 1. Zinc and cadmium plasma and erythrocyte levels in prostatic carcinoma, BPH, urological malignancies, and inflammations.
    Feustel A; Wennrich R
    Prostate; 1986; 8(1):75-9. PubMed ID: 2418432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc plasma levels in prostatic carcinoma and BPH.
    Lekili M; Ergen A; Celebi I
    Int Urol Nephrol; 1991; 23(2):151-4. PubMed ID: 1713903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH).
    Feustel A; Wennrich R; Steiniger D; Klauss P
    Urol Res; 1982; 10(6):301-3. PubMed ID: 6186062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the distribution of zinc and cadmium in cellular fractions of BPH, normal prostate and prostatic cancers of different histologies by atomic and laser absorption spectrometry in tissue slices.
    Feustel A; Wennrich R
    Urol Res; 1984; 12(5):253-6. PubMed ID: 6083653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc and cadmium analysis in human prostate neoplasms.
    Bryś M; Nawrocka AD; Miekoś E; Zydek C; Foksiński M; Barecki A; Krajewska WM
    Biol Trace Elem Res; 1997; 59(1-3):145-52. PubMed ID: 9522056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc and cadmium in cell fractions of prostatic cancer tissues of different histological grading in comparison to BPH and normal prostate.
    Feustel A; Wennrich R
    Urol Res; 1984; 12(2):147-50. PubMed ID: 6204433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor M2 pyruvate kinase in plasma of patients with urological tumors.
    Roigas J; Schulze G; Raytarowski S; Jung K; Schnorr D; Loening SA
    Tumour Biol; 2001; 22(5):282-5. PubMed ID: 11553857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.
    Ogunlewe JO; Osegbe DN
    Cancer; 1989 Apr; 63(7):1388-92. PubMed ID: 2465818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum zinc level and prostatic lesion.
    Rahman MT; Mumu MA; Kabir Y; Choudhury MM; Saiedullah M
    Mymensingh Med J; 2012 Oct; 21(4):679-83. PubMed ID: 23134917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-Zn-levels in prostatic cancer.
    Feustel A; Wennrich R; Schmidt B
    Urol Res; 1989; 17(1):41-2. PubMed ID: 2922890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum granulocyte colony-stimulating factor levels in patients with urinary bladder tumour and various urological malignancies.
    Mizutani Y; Okada Y; Terachi T; Kakehi Y; Yoshida O
    Br J Urol; 1995 Nov; 76(5):580-6. PubMed ID: 8535676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levels of cadmium, zinc, copper and selenium in subjects with diagnosed prostate cancer].
    Daragó A; Sapota A; Duda-Szymańska J
    Rocz Panstw Zakl Hig; 2003; 54 Suppl():39-40. PubMed ID: 12884501
    [No Abstract]   [Full Text] [Related]  

  • 13. [The modification of different element levels in human blood by occupational cadmium exposure].
    Kraus G; Schaller KH; Winter L
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1988 May; 186(2):95-107. PubMed ID: 3138836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia.
    Aydin A; Arsova-Sarafinovska Z; Sayal A; Eken A; Erdem O; Erten K; Ozgök Y; Dimovski A
    Clin Biochem; 2006 Feb; 39(2):176-9. PubMed ID: 16413012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
    Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
    Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte polyamine levels in human prostatic carcinoma.
    Cipolla B; Moulinoux JP; Quemener V; Havouis R; Martin LA; Guille F; Lobel B
    J Urol; 1990 Nov; 144(5):1164-6. PubMed ID: 1700142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc and magnesium serum levels in patients with benign prostatic hyperplasia (BPH) before and after prazosin therapy.
    Dutkiewicz S
    Mater Med Pol; 1995; 27(1):15-7. PubMed ID: 8569270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma zinc legels in prostatic disease.
    Willden EG; Robinson MR
    Br J Urol; 1975 Jun; 47(3):295-9. PubMed ID: 49204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.